The Form 144 signals a director's intent to sell a modest but non-trivial stake. Monitor for actual execution via Form 4 filings; if the full block is sold, it may indicate a lack of near-term confidence despite recent positive momentum. The sale is not large enough to be a standalone bearish signal but warrants attention given the director's role.
Price Chart
Executive Summary
Director George M. Jenkins filed a Form 144 notice of intent to sell 27,500 shares of Palvelia Therapeutics common stock, with an estimated aggregate market value of approximately $3.7 million based on the filing date.
Key Facts
- Director George M. Jenkins filed Form 144 to sell 27,500 shares of common stock.
- Estimated aggregate market value of the proposed sale is approximately $3,695,450.
- Shares were acquired on 03/06/2017 via a private investment.
- The sale is to be executed through Piper Sandler & Co.
- Jenkins beneficially owns 14,408,407 shares of common stock after the sale.
- The filing date is 10/13/2026, with the proposed sale date also 10/13/2026.
Financial Impact
Sale of 27,500 shares valued at ~$3.7 million, representing ~0.19% of total shares outstanding.
Risk Factors
- Insider selling could be perceived as a lack of confidence in near-term prospects.
- The sale may precede a negative catalyst or earnings miss.
- If the full 27,500 shares are sold, it could pressure the stock price in a thin market.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001967940-26-000053 |
| Document: 0001967940-26-000053-index.html | 0001967940-26-000053 |
| Document: 0001967940-26-000053.txt | 0001967940-26-000053 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 28, 2026 today | SC 13G/A | $145.43 | awaiting T+60 | awaiting T+60 | $147.47 (+1.40%) |
Oct 28, 2026 today | 8-K | $133.63 | awaiting T+60 | awaiting T+60 | $147.47 (+10.36%) |
Oct 28, 2026 today | Press Release | $133.63 | awaiting T+60 | awaiting T+60 | $147.47 (+10.36%) |
Oct 23, 2026 5d ago | Insider Cluster | $126.23 | awaiting T+60 | awaiting T+60 | $147.47 (+16.83%) |
Oct 15, 2026 13d ago | Press Release | $127.34 | awaiting T+60 | awaiting T+60 | $147.47 (+15.81%) |
Oct 13, 2026 15d ago | 144 | $122.58 | awaiting T+60 | awaiting T+60 | $147.47 (+20.31%) |
Sep 18, 2026 5w ago | Insider Cluster | $153.41 | awaiting T+60 | awaiting T+60 | $147.47 (+3.87%) |
Sep 2, 2026 8w ago | 144 | $155.47 | awaiting T+60 | awaiting T+60 | $147.47 (−5.15%) |
Aug 9, 2026 11w ago | Institutional Cluster | $152.22 | awaiting T+60 | awaiting T+60 | $147.47 (−3.12%) |
Aug 4, 2026 12w ago | 8-K | $151.99 $132.91 | ▼ −12.55% | ▼ −12.93% | $147.47 (−2.97%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers